Navigation Links
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
Date:6/2/2008

ytarabine (Ara-C) to cytarabine alone.

A second phase 3 study of clofarabine sponsored by the Eastern Cooperative Oncology Group is expected to begin enrolling patients next year. This study will compare single agent clofarabine to conventional induction chemotherapy in untreated AML patients age 60 and older who are considered suitable for conventional induction chemotherapy.

Clolar is indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory ALL after at least two prior regimens. This use is based on the induction of complete responses. Randomized trials demonstrating increased survival or other clinical benefit have not been conducted.

Genzyme also is actively exploring additional therapeutic indications for Clolar, including in MDS.

Genzyme Hosts Investor Call Tomorrow Morning

Genzyme will host an investor call tomorrow morning, Tuesday, June 3 at 10 a.m. EST. The preliminary data from the CLASSIC-II pivotal study will be reviewed and there will be opportunity for investors to ask questions of Genzyme.

To participate in the call, please dial 1-888-982-7287 in the U.S. or 1-210-234-0251 outside of the U.S. The participant passcode is "Genzyme."

A replay of this call will be available by dialing 1-800-695-3397. This call will also be available live on the investor events section of http://www.genzyme.com. Replays of the call will be available until 10:59 p.m. on June 10, 2008.

About Clolar

Clolar has Orphan Drug designation for adult and pediatric ALL, and seven years of market exclusivity in the United States for relapsed/refractory pediatric ALL. The FDA also granted six months of extended market exclusivity to Clolar under the Best Pharmaceuticals for Children Act.

Clolar should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... TAIPEI , May 4, 2015 ... partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... BAX ) jointly announced that Baxter has ... European Medicines Agency (EMA) for MM-398 (irinotecan liposome ... metastatic adenocarcinoma of the pancreas who have been ...
(Date:5/4/2015)...  Makindus, Inc. a specialty pharmaceutical development company focused ... (EMA) has granted orphan drug designation for their lead ... "We are extremely pleased to now have orphan ... place for Europe . This complements ... United States for which orphan designation has ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
Breaking Medicine Technology:PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3
... TechPrecision Corporation (OTC Bulletin Board: ... manufacturer of large-scale, high-precision metal machining fabrications and ... nuclear, defense, aerospace and other commercial industries, today ... purchase order valued at approximately $450,000.  The order, ...
... Inc. today announced that it has expanded its ... gene, CYP2C9, to further support clinicians in prescribing medications ... of the CYP2C9 gene, variations of which can cause ... psychotropic medications, provides physicians with further information on gene ...
Cached Medicine Technology:TechPrecision Corporation Receives New $450,000 Medical Purchase Order 2AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing 2AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing 3
(Date:5/4/2015)... The National Association of Professional Women ... 2015-2016 inductee into the NAPW VIP Woman of the ... for leadership in oral healthcare. NAPW is the nation's ... than 700,000 members and over 200 operating Local Chapters. ... group of professional women," said NAPW President Star Jones. ...
(Date:5/4/2015)... Montreal, CANADA (PRWEB) May 04, 2015 ... development of innovative proofreading technologies, today announced that ... #438 at the Music City Center, in Nashville ... Proofware is the world's first true all-in-one we-based ... everyone involved in the security of their brand ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The ... Group today launched a new initiative at UC ... next generation of physicians committed to advancing Latino ... Ser Medicos, or Preparing Students to Be Physicians, ... that will provide scholarships, mentorship and internship opportunities, ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Getting patients ... manage their health is critical to achieving the “triple ... reducing costs, but this will require a shift in ... also demands that health systems move beyond their traditional ... took part in the third live meeting of the ...
(Date:5/4/2015)... 04, 2015 The American Telemedicine Association ... policy reports which identify gaps in coverage and reimbursement, ... issued the State Telemedicine Gaps Reports last September, many ... laws and regulations impact healthcare delivery in their state,” ... of state actions across the nation, ATA reevaluated the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Elizabeth Moncada, Owner, Moncada Center for Orofacial Pain, into its 2015-2016 VIP Woman of the Year Circle 2Health News:Global Vision to Spotlight Proofware at INFO*FLEX 2015 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 2Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 3Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 4Health News:New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health 5Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3
... Nielsen Company , a leading global information and media company ... advertising and design competitions, announced today that the first-ever ... at www.CLIOHealthcare.com . The submission deadline is August ... June 30, 2009. , , "We are looking forward to ...
... psychiatrists and psychologists from The Child Study Center at NYU ... parents face today , , Expert advice and tips ... disorders, depression, anxiety, homosexuality and more explored on marathon of Doctor ... 1 SIRIUS XM Radio (Nasdaq: SIRI ) today ...
... pilot prevention program targeting fifth graders and their younger ... on Drug Abuse as part of the National Institutes ... award is for two years. The program aims ... and thereby decrease risky behavior and use of drugs ...
... determined that movie characters who smoke, regardless of whether they ... smoking. The study, published in the July 2009 issue of ... Matters More, Good Guys or Bad Guys?" "Previous studies ... initiation of smoking by adolescents, and we wanted to dig ...
... for Dedication to Improving Animal Health and Well-Being , ... for the third annual Thank Your Vet for a ... The national short-essay contest honors America,s veterinarians for their ... have with our pets. The nationwide essay contest runs ...
... National Alliance on Mental Illness (NAMI) reminds Americans that July ... a time for public education about serious mental illness in ... House of Representatives designated July as Bebe Moore Campbell National ... African American novelist and journalist, who also was a voice ...
Cached Medicine News:Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries 2Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries 3Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 2Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 3Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 4Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 5Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 6Health News:Both good/bad movie characters who smoke influence teens to do the same 2Health News:Search for America's Best Veterinarian Continues With Third Annual 'Thank Your Vet for a Healthy Pet(R)' Contest 2Health News:NAMI Observes Minority Mental Health Awareness Month 2
PVC Sealing Tape, 100/Box...
Mylar Plate Sealers 100/Box...
OptiTape - Optically Clear sealing tape for OmniUltra PCR plates. 250 sheet roll....
TDX Tape - sealing sheets for polypropylene plates only, 100/PK...
Medicine Products: